The next few months will be crucial for obesity players Eli Lilly, Novo Nordisk and Amgen.

Randox is working with Bosch Healthcare to make a point of care test that can give results in three hours. Takeda is partnering with public bodies and pharma and Europe’s Innovative Medicines ...

Some clinical trials test new drugs, while others test existing drugs for new uses. The best pharmaceutical companies are adept at both developing new therapies and using existing drugs for new ...

As per reports, Sun Pharma’s Ursocol 300 was flagged as well. These drugs were deemed to have failed the quality test, with ...

Silo Pharma (SILO) announced promising results from recent sterilization and dissolution tests of its SP-26 ketamine-loaded implant for ...

I write about business model strategy and execution across healthcare. Pharmaceutical executives are waking up to a hard new reality. The winds of healthcare economic change, accelerated by a ...

PurpleLab® stands out from others in this sector by providing its data analytics services to several different groups of users across healthcare and pharma companies. Healthcare is a data-driven ...

In its recent ‘Not of Standard Quality’ (NSQ) alert for August, the drug regulator identified a number of top-selling drugs manufactured by major pharmaceutical companies such as Alkem ...

The global pharmaceutical industry will generate more than $1.2 trillion in sales in 2025, according to Statista. A large portion of that figure is from the oncology segment, which is expected to ...

Amid a transformation effort under CEO Christophe Bourdon, Danish dermatology expert Leo Pharma is embarking on another round of layoffs and relocations. As part of the “next step” in the ...

PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative ...

The implant demonstrates stability and consistent drug release, supporting further analytical testing and developmentSARASOTA, FL, Oct. 31, 2024 ...